Affinity Asset Advisors, LLC Pulmonx Corp Transaction History

Affinity Asset Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$29.72 - $45.1 $743,000 - $1.13 Million	-25,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$35.98 - $44.48 $1.26 Million - $1.56 Million	-35,000 Reduced 58.33%	25,000 $900,000
Q2 2021 Aug 13, 2021	BUY	$37.61 - $48.0 $564,150 - $720,000	15,000 Added 33.33%	60,000 $2.65 Million
Q1 2021 May 14, 2021	BUY	$44.0 - $67.54 $1.1 Million - $1.69 Million	25,000 Added 125.0%	45,000 $2.06 Million
Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $786,200 - $1.38 Million	20,000 New	20,000 $1.38 Million

124

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $233M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Asset Advisors, LLC with notifications on news.